Acute Condition

Introducing The Remedy

I find myself launching a second newsletter (forgive me and please sign up)

Feb 20 • Olivia Webb Kosloff

6

3

What a time to be an oncologist

The rush to capture oncologists' attention

Feb 5 • Olivia Webb Kosloff

9

2

January 2026

Is China really destroying Boston biotech?

Competition and stagnation

Jan 22 • Olivia Webb Kosloff

11

7

3

Everything in healthcare is a bank now

More inefficiency = greater returns for some

Jan 8 • Olivia Webb Kosloff

12

2

December 2025

From the archive: Dry ice and millions of secret chickens

When the government absolutely has to get involved in production

Dec 23, 2025 • Olivia Webb Kosloff

4

1

Will expensive cell and gene therapies force a different insurance structure?

Or we’ll all just suffer instead

Dec 16, 2025 • Olivia Webb Kosloff

11

3

Company size is warping the healthcare market

Healthcare startups are stuck playing an Amazon HQ2 game

Dec 5, 2025 • Olivia Webb Kosloff

10

2

November 2025

Botulism, recalls, and the open weaknesses in America’s formula supply

The structural flaws that make our formula manufacturing vulnerable

Nov 20, 2025 • Olivia Webb Kosloff

5

The end of the independent doctor and the future of healthcare reform

The doctors become the working class

Nov 12, 2025 • Olivia Webb Kosloff

13

October 2025

The war of pricing bots

Accelerationism...but for downcoding

Oct 29, 2025 • Olivia Webb Kosloff

8

1

Provider consolidation: an interview with Health Tech Nerds's Martin Cech

I talked to Martin, HTN's Lead Policy Research Analyst, about provider independence

Oct 22, 2025 • Olivia Webb Kosloff

8

1

MultiPlan: still secretive, still there

Now with tools that make things even harder on providers and patients

Oct 17, 2025 • Olivia Webb Kosloff

9